Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02120677 · ClinicalTrials.gov registry record · Early Phase 1
Topical Itraconazole in the Treatment of Basal Cell Carcinoma
A Early Phase 1 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 5
- Enrollment target
NCT02120677: Completed Early Phase 1 study, sponsored by Johns Hopkins University.
NCT02120677 is a Early Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 5 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02120677, a Early Phase 1 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
This research is being done to study the molecular effects of topically applied itraconazole ointment on the growth of basal cell carcinomas.
Primary Outcome
We will report the proportion of patients by treatment cohort and overall that had a significant downregulation in GLI.
Interventions
- DRUG Itraconazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2014-05 |
| Est. Completion | 2019-01-30 |
| Phase | Early Phase 1 |
What the finished NCT02120677 record still lists
NCT02120677 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 1 intervention - of which Itraconazole is the first listed.
NCT02120677 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02120677 about?
NCT02120677 is a clinical study titled "Topical Itraconazole in the Treatment of Basal Cell Carcinoma". This research is being done to study the molecular effects of topically applied itraconazole ointment on the growth of basal cell carcinomas.
What is the current status of trial NCT02120677?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 5 participants. The study started on 2014-05. Estimated completion is 2019-01-30.
What interventions are being tested in trial NCT02120677?
The interventions under investigation include: Itraconazole (DRUG).
Who is sponsoring clinical trial NCT02120677?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02120677's enrollment target sits among peer trials
5 1888th of 2000 higher than 80 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia